824 resultados para PANDEMIC INFLUENZA A (H1N1)
Resumo:
Mode of access: Internet.
Resumo:
Cover title has imprint: Studio Bibliografico A. Polla, Roma.
Resumo:
Mode of access: Internet.
Resumo:
Includes bibliographical references.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
In Scrittori classici italiani di economia politica. Milano, 1804. 22 cm. [v. 38] Parte moderna, p. [5]-106.
Resumo:
"Estratto dal vol. 34 degli annali Univ. de Med."
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Thesis (Ph.D.)--University of Washington, 2016-06
Resumo:
A 5'-nuclease real-time reverse transcriptase-polymerase chain reaction assay was developed for the detection of influenza type A and was validated using a range of influenza A subtypes, including avian strains, and 126 nasopharyngeal aspirate samples. The results show the assay is suitable for screening for influenza A infections, particularly in regions where avian strains may be circulating. (c) 2005 Elsevier Inc. All rights reserved.
Resumo:
Neuraminidase inhibitors, oseltamivir and zanamivir, are used for the treatment of, and protection from, influenza. The safety of these compounds has been assessed in systematic reviews. However, the data presented are somewhat limited by the paucity of good quality adverse event data available. The majority of safety outcomes are based on evidence from just one or two randomised controlled trials. The results of the systematic reviews suggest that neuraminidase inhibitors have a reasonable side effect and adverse effect profile if they are to be used to treat or protect patients against a life-threatening disease. However, if these compounds are to be prescribed in situations in which avoidance of inconvenience or minor discomfort is hoped for, then the balance of harms to benefits will be more difficult to judge.